Lung Health Institute

8140 Walnut Hill Lane, Suite 570
Dallas, TX 75231
Hours: Monday–Friday 8 a.m.- 4:30 p.m.

Our clinic is about five miles from downtown Dallas and has easy access to Interstate 75. It is located on the 5th floor of the One Glen Lakes office building. All patient rooms have windows with nice, bright natural light. There is also a deli located in the building.

The Lung Health Institute in Dallas, Tx, offers cutting edge solutions for those who suffer from chronic lung disease. They say everything is bigger in Texas, and Dallas is no exception.

Our Dallas location has four treatment rooms, each with a nebulizer machine and an oxygen concentrator to enhance the patient experience. The clinic also has a consult suite and a lab.

We are ready to help you have a positive patient experience as you address lung inflammation.


Contact Us

Call Toll-Free: 888-745-6697


Find out if you qualify!


Important Notice

The safety and well-being of the chronic lung disease patients who we treat are our top priority. As those suffering from chronic lung disease are at high risk of exposure to COVID-19, we recommend all patients follow guidelines issued by the CDC, and if you are feeling unwell, please take steps to safeguard others and remain at home.

Lung Health Institute has decided as a precautionary measure to implement a break in treatment and have temporarily closed our clinics to potentially help prevent the spread of COVID-19. We will be taking your phone calls, answering your health care related questions in the meantime.

We have learned that many regenerative medicine clinics are making claims that stem cells, cellular therapy, etc., can be used to treat people infected with COVID-19. While stem cell and regenerative medicine research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based or regenerative medicine-based approaches for the prevention and treatment of COVID-19 infection.

There remains hope as a number of regenerative medicine and other health care organizations are working to submit therapies to regulatory agencies, which is the appropriate and correct avenue for any health care organization working on testing a solution in rigorous clinical trials.